Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Day:
June 20, 2023
USFDA 483 (Aug 2021) & Warning lette
Aurobindo Unit 1 (FEI 3004021253) was inspected by USFDA investigator Rita K Kabaso from August
Qvents
June 20, 2023
USFDA 483 (Aug 2021) & Warning lette
Aurobindo Unit 1 (FEI 3004021253) was inspected by USFDA investigator Rita K Kabaso from August
Qvents
June 20, 2023
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Qvents Apps and Tools For QMS and GMP Processes
August 8, 2025
Glenmark Warning Letter Cites 21 CFR 211.192 Violations at Multiple Sites
August 7, 2025
Natco Pharma USFDA 483 Flags Deficiencies in Aseptic Areas, Validation
August 2, 2025
Loss of Potency: Accord / Intas Recall Hypothyroidism / Thyroxine Drug
July 25, 2025
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
June 28, 2025
